Literature DB >> 22976954

Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke.

Mathias Gelderblom1, Anna Weymar, Christian Bernreuther, Joachim Velden, Priyadharshini Arunachalam, Karin Steinbach, Ellen Orthey, Thiruma V Arumugam, Frank Leypoldt, Olga Simova, Vivien Thom, Manuel A Friese, Immo Prinz, Christoph Hölscher, Markus Glatzel, Thomas Korn, Christian Gerloff, Eva Tolosa, Tim Magnus.   

Abstract

The devastating effect of ischemic stroke is attenuated in mice lacking conventional and unconventional T cells, suggesting that inflammation enhances tissue damage in cerebral ischemia. We explored the functional role of αβ and γδ T cells in a murine model of stroke and distinguished 2 different T cell-dependent proinflammatory pathways in ischemia-reperfusion injury. IFN-γ produced by CD4(+) T cells induced TNF-α production in macrophages, whereas IL-17A secreted by γδ T cells led to neutrophil recruitment. The synergistic effect of TNF-α and IL-17A on astrocytes resulted in enhanced secretion of CXCL-1, a neutrophil chemoattractant. Application of an IL-17A-blocking antibody within 3 hours after stroke induction decreased infarct size and improved neurologic outcome in the murine model. In autoptic brain tissue of patients who had a stroke, we detected IL-17A-positive lymphocytes, suggesting that this aspect of the inflammatory cascade is also relevant in the human brain. We propose that selective targeting of IL-17A signaling might provide a new therapeutic option for the treatment of stroke.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976954     DOI: 10.1182/blood-2012-02-412726

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  163 in total

1.  Gut Microbiota-Derived Short-Chain Fatty Acids Promote Poststroke Recovery in Aged Mice.

Authors:  Juneyoung Lee; John d'Aigle; Louise Atadja; Victoria Quaicoe; Pedram Honarpisheh; Bhanu P Ganesh; Ahmad Hassan; Joerg Graf; Joseph Petrosino; Nagireddy Putluri; Liang Zhu; David J Durgan; Robert M Bryan; Louise D McCullough; Venugopal Reddy Venna
Journal:  Circ Res       Date:  2020-05-01       Impact factor: 17.367

2.  Intravenous Immunoglobulin (IVIg) Induce a Protective Phenotype in Microglia Preventing Neuronal Cell Death in Ischaemic Stroke.

Authors:  Vivien Häußler; Tristan Daehn; Björn Rissiek; Vanessa Roth; Christian Gerloff; Thiruma V Arumugam; Tim Magnus; Mathias Gelderblom
Journal:  Neuromolecular Med       Date:  2019-09-26       Impact factor: 3.843

3.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 4.  The role of peripheral immune cells in the CNS in steady state and disease.

Authors:  Marco Prinz; Josef Priller
Journal:  Nat Neurosci       Date:  2017-01-16       Impact factor: 24.884

Review 5.  Promises and limitations of immune cell-based therapies in neurological disorders.

Authors:  Xiaoming Hu; Rehana K Leak; Angus W Thomson; Fang Yu; Yuguo Xia; Lawrence R Wechsler; Jun Chen
Journal:  Nat Rev Neurol       Date:  2018-09       Impact factor: 42.937

Review 6.  Inflammation and Stroke: An Overview.

Authors:  Josef Anrather; Costantino Iadecola
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 7.  IL-17+ γδ T cells as kick-starters of inflammation.

Authors:  Pedro H Papotto; Julie C Ribot; Bruno Silva-Santos
Journal:  Nat Immunol       Date:  2017-05-18       Impact factor: 25.606

8.  Chilled to the marrow: neonatal brain injury, hypothermia, and the immune system*.

Authors:  Sujatha Kannan
Journal:  Pediatr Crit Care Med       Date:  2013-10       Impact factor: 3.624

Review 9.  T cells in organ ischemia reperfusion injury.

Authors:  Jianhua Rao; Ling Lu; Yuan Zhai
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

Review 10.  Long-term T cell responses in the brain after an ischemic stroke.

Authors:  Uma Maheswari Selvaraj; Ann M Stowe
Journal:  Discov Med       Date:  2017-12       Impact factor: 2.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.